To clarify whether levels of SELENBP1 expression are associated with ER status in breast cancer, we analyzed SELENBP1 expression levels with respect to ER+ and ER– samples as well as the patient survival within the ER+ patients. This evidence concerns the gene ESR1 and breast carcinoma.